At the November PD Active Forum, Jaimie Henderson, MD, neurosurgeon from Stanford University will speak on “Surgical Options for PD: DBS and Beyond.” He will address various surgical alternatives for Parkinson’s, including deep brain stimulation (DBS) surgery. PD Active requests a $10 contribution. Register now.
Register with PD Active
Suggested $10 donation to the host, PD Active
About the speaker:
Dr. Jaimie Henderson is the director of stereotactic and functional neurosurgery at Stanford. He received his MD from Chicago’s Rush Medical College, completed his residency in Neurosurgery at Saint Louis University and fellowship training in Stereotactic and Functional Neurosurgery. Following his residency and fellowship training, he developed the movement disorders surgery program at St. Louis University, where he remained on staff for 7 years. He then moved to the Cleveland Clinic Foundation, where he developed innovative surgical techniques for DBS placement. He has directed the Stereotactic and Functional Neurosurgery program at Stanford since 2004.
Dr. Henderson is an expert in the surgical treatment of movement disorders and chronic pain, and is active in research to improve stereotactic navigation and the efficacy of neuromodulatory therapies for movement disorders, pain, and other neurological diseases. Dr. Henderson is one of the world’s foremost experts on the application of image-guided surgical techniques to functional neurosurgical procedures such as the placement of DBS for movement disorders, epilepsy, pain, and psychiatric diseases. This innovative technology has revolutionized the practice of neurosurgery, allowing for safer and more effective operations with reduced operating time. His groundbreaking work on frameless functional neurosurgery has become the standard technique for many neurosurgeons throughout the world.
Dr. Henderson’s research encompasses several areas of stereotactic and functional neurosurgery. He collaborates closely with Krishna Shenoy, Ph.D., (Departments of Neuroscience and Electrical Engineering) on the development of neural prosthetic systems and understanding of the cortical control of movement. His work with Karl Deisseroth, M.D., Ph.D. (Departments of Psychiatry and Bioengineering) explores the combination of gene therapy and light to understand the circuitry of Parkinson’s disease and to develop innovative new therapies for brain and spinal cord disorders. Formerly the president of the North American Neuromodulation Society, Dr. Henderson continues to spearhead policy efforts at state and national levels to ensure access to neuromodulation technologies for patients with severe chronic disease.